Management of Locally Advanced Cholangiocarcinoma With Comorbid Rheumatoid Arthritis
Management of Locally Advanced Cholangiocarcinoma With Comorbid Rheumatoid Arthritis is organized by Projects In Knowledge Inc. (PIK).
Release Date: May 05, 2023
Termination Date: May 04, 2024
Activity Goal:
The goal of this program is to provide data from medical meetings, expert analysis insights on current and emerging management strategies, and interactive case studies based on the most up-to-date evidence-based medicine and clinical trial results in advanced cholangiocarcinoma.
Learning Objective(s):
• Employ a patient-centered strategy for the first-line treatment of local advanced cholangiocarcinoma in a patient with comorbid rheumatologic disease utilizing immunotherapy.
• Review key data on durvalumab plus gemcitabine and cisplatin for the first-line treatment of advanced or metastatic intrahepatic cholangiocarcinoma.
• Summarize strategies for the first and subsequent lines of treatment of advanced or metastatic cholangiocarcinoma, including targeted therapy for actionable mutations.